Compare PCT & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCT | CERT |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | 174 | N/A |
| Industry | Environmental Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 955.4M | 860.9M |
| IPO Year | N/A | 2020 |
| Metric | PCT | CERT |
|---|---|---|
| Price | $7.55 | $6.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $13.00 | $11.67 |
| AVG Volume (30 Days) | ★ 3.4M | 2.8M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $380.44 | $4.18 |
| Revenue Next Year | $203.33 | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $4.93 | $5.19 |
| 52 Week High | $17.37 | $13.88 |
| Indicator | PCT | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 61.71 | 50.64 |
| Support Level | $7.52 | $6.04 |
| Resistance Level | $9.56 | $6.48 |
| Average True Range (ATR) | 0.46 | 0.27 |
| MACD | 0.09 | 0.04 |
| Stochastic Oscillator | 73.21 | 51.49 |
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.